Percheron Therapeutics to trial Hmbd-002 in acute myeloid leukemia
Percheron Therapeutics says Vanderbilt Health will conduct a clinical trial of Hmbd-002 in acute myeloid leukemia.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.